Parenteral nutrition in the hospital setting/short-term parenteral nutrition.

Autor:	Cogle SV; Department of Pharmacy, Clinical Programs, Vanderbilt University Medical Center, Nashville, TN, USA., Ayers P; Clinical Pharmacy Services, Department of Pharmacy, Baptist Medical Center, Jackson, MS, USA., Berger MM; Service of Adult Intensive Care, Lausanne University Hospital (CHUV), Lausanne, Switzerland., Berlana D; Pharmacy Service, Vall d'Hebron Barcelona Hospital Campus and Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain., Wischmeyer PE; Department of Anesthesiology and Surgery, Duke University School of Medicine, Durham, NC, USA., Ybarra J; Steward Health Care, Dallas, TX, USA., Zeraschi S; Pharmacy Department and Nutrition and Intestinal Failure Services, Leeds Teaching Hospitals NHS Trust, Leeds, UK., De Cloet J; Pharmacy Department, Ghent University Hospital, Ghent, Belgium.
Jazyk:	angličtina
Zdroj:	American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2024 Jun 13; Vol. 81 (Supplement_3), pp. S102-S111.
DOI:	10.1093/ajhp/zxae080
Abstrakt:	Purpose: This article is based on presentations and discussions held at the International Safety and Quality of Parenteral Nutrition (PN) Summit concerning the acute care setting. Some European practices presented in this article do not conform with USP general chapter <797> requirements. Nevertheless, the purpose is to cover the challenges experienced in delivering high-quality PN within hospitals in the United States and Europe, in order to share best practices and experiences more widely. Summary: Core issues regarding the PN process within an acute care setting are largely the same everywhere: There are ongoing pressures for greater efficiency, optimization, and also concurrent commitments to make PN safer for patients. Within Europe, in recent years, the use of market-authorized multi-chamber bags (MCBs) has increased greatly, mainly for safety, cost-effectiveness, and efficiency purposes. However, in the US, hospitals with low PN volumes may face particular challenges, as automated compounding equipment is often unaffordable in this setting and the variety of available MCBs is limited. This can result in the need to operate several PN systems in parallel, adding to the complexity of the PN use process. Ongoing PN quality and safety initiatives from US institutions with various PN volumes are presented. In the future, the availability of a greater selection of MCBs in the US may increase, leading to a reduction in dependence on compounded PN, as has been seen in many European countries. Conclusion: The examples presented may encourage improvements in the safety and quality of PN within the acute care setting worldwide. (© American Society of Health-System Pharmacists 2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu